Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Granulocyte Transfusion in Febrile Neutropenia

Gonul Aydogan, Gonca Keskindemirci, Deniz Tugcu, Ferhan Akici, Zafer Salcioglu, Arzu Akcay, Hulya Sen, Muge Gokce, Cengiz Bayram, Ali Aycicek, Nuray Aktay Ayaz

Blood (2015) 126 (23): 4612.

https://doi.org/10.1182/blood.V126.23.4612.4612

Published: 2015

Journal Articles

A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy

Courtney D. DiNardo, MD, Fleur M. Aung, MD, Fernando Martinez, MD MPH, Naval Daver, MD, Tapan Kadia, MD, Nitin Jain, MD, Elias Jabbour, MD, Naveen Pemmaraju, MD, Virgil M Reddy, MBBS, Guillermo Garcia-Manero, MD, Jorge Cortes, MD, Farhad Ravandi, MD, Hagop M. Kantarjian, MD, Benjamin Lichtiger, MDPhD, Emil J. Freireich, MD

Blood (2014) 124 (21): 1564.

https://doi.org/10.1182/blood.V124.21.1564.1564

Published: 2014

Journal Articles

Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

M Domenica Cappellini, MD, Amal El-Beshlawy, MD, John B Porter, MD, Antonis Kattamis, MD, PhD, Kerry Taylor, MD, Christian Rose, Vernon J Louw, MD, Ali El-Ali, MD, Nicolas Martin, MS, Norbert Gattermann, MD

Blood (2012) 120 (21): 5182.

https://doi.org/10.1182/blood.V120.21.5182.5182

Published: 2012

Journal Articles

Merging of Children's Oncology Group and Pediatric Health Information Systems Data to Determine Resource Utilization and Treatment Costs on AAML0531: A Report From the Children's Oncology Group

Richard Aplenc, MD, PhD, Brian T. Fisher, DO, MSCE, Lillian Sung, MD, PhD, Ron Keren, MD, MSCE, Todd A. Alonzo, PhD, Mathew Hall, PhD, Yuan-Shung V. Huang, MS, Yimei Li, PhD, Xianqun Luan, PhD, Robert B. Gerbing, M.A., David Bertoch, MS, Alix E. Seif, MD, MPH, Peter C. Adamson, MD, Alan S. Gamis, MD, MPH

Blood (2011) 118 (21): 2617.

https://doi.org/10.1182/blood.V118.21.2617.2617

Published: 2011

Journal Articles

A Phase Ib Study Combining the mTOR Inhibitor Everolimus (RAD001) with Low-Dose Cytarabine In Untreated Elderly AML

Andrew H Wei, MBBS, PhD, Sonali Sadawarte, John Catalano, MBBS, FRACP, FRCPA, Robert Hills, MA, MSc, DPhil, Sharon Avery, MBBS, Sushrut S. Patil, FRACP, FRCPA, Alan Burnett, Andrew Spencer, MD

Blood (2010) 116 (21): 3299.

https://doi.org/10.1182/blood.V116.21.3299.3299

Published: 2010

Journal Articles

Empirical Vs. Prophylactic Antifungal Strategies: Comparison of Effectiveness In High Risk AML Patients at a Tertiary Cancer Center

Dennis Gutmann, Jan Felix Kersten, Philippe Schafhausen, MD, Tim H. Brummendorf, MD, Martin Trepel, MD, PhD, Carsten Bokemeyer, MD, Jens Panse, MD

Blood (2010) 116 (21): 1729.

https://doi.org/10.1182/blood.V116.21.1729.1729

Published: 2010

Journal Articles

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years.

James Foran, MD, Angelina The, MD, Pam Dixon, RN, Marcel Devetten, MD, Mikkael Sekeres, MD

Blood (2007) 110 (11): 1831.

https://doi.org/10.1182/blood.V110.11.1831.1831

Published: 2007

Journal Articles

Acute Enterocolitis Incidence in Patients with Hematological Malignancies Receiving Myelotoxic Therapy Requiring Hematopoietic Stem Cell Support - Palifermin Experience.

Isabel Sousa, MD, Catarina Geraldes, MD

Blood (2006) 108 (11): 5461.

https://doi.org/10.1182/blood.V108.11.5461.5461

Published: 2006

Journal Articles

Cord Blood Transplantation for Lysosomal Storage Diseases Demonstrates the Potential of Cord Blood Cells for Future Cellular Therapies.

Joanne Kurtzberg, MD, William Krivit, MD

Blood (2004) 104 (11): 3602.

https://doi.org/10.1182/blood.V104.11.3602.3602

Published: 2004

Journal Articles

Mechanisms of Leukemogenesis by MLL-CALM: Characterization of a CALM-Derived Transcriptional Regulatory Domain.

Mwe Mwe Chao, MD, Emily J. Fox, Daniel S. Wechsler, MD, PhD.

Blood (2004) 104 (11): 3387.

https://doi.org/10.1182/blood.V104.11.3387.3387

Published: 2004

NARROW

Granulocyte Transfusion in Febrile Neutropenia

A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Therapy

Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

Merging of Children's Oncology Group and Pediatric Health Information Systems Data to Determine Resource Utilization and Treatment Costs on AAML0531: A Report From the Children's Oncology Group

A Phase Ib Study Combining the mTOR Inhibitor Everolimus (RAD001) with Low-Dose Cytarabine In Untreated Elderly AML

Empirical Vs. Prophylactic Antifungal Strategies: Comparison of Effectiveness In High Risk AML Patients at a Tertiary Cancer Center

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years.

Acute Enterocolitis Incidence in Patients with Hematological Malignancies Receiving Myelotoxic Therapy Requiring Hematopoietic Stem Cell Support - Palifermin Experience.

Cord Blood Transplantation for Lysosomal Storage Diseases Demonstrates the Potential of Cord Blood Cells for Future Cellular Therapies.

Mechanisms of Leukemogenesis by MLL-CALM: Characterization of a CALM-Derived Transcriptional Regulatory Domain.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only